XML 22 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Stockholders’ (Deficit) Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ 9 $ 957,730 $ (1,051,360) $ (93,621)
Balance (in Shares) at Dec. 31, 2021 8,597,000      
Shares issued for sale of common stock, net of cost 2,454 2,454
Shares issued for sale of common stock, net of cost (in Shares) 565,000      
Lender warrants 2,727 2,727
Rounding for fractional shares in connection with the reverse stock split
Rounding for fractional shares in connection with the reverse stock split (in Shares) 142,000      
Shares issued for vested restricted and performance stock units
Shares issued for vested restricted and performance stock units (in Shares) 189,000      
Shares issued for sale of common stock related to employee stock purchase plan 14 14
Shares issued for sale of common stock related to employee stock purchase plan (in Shares) 5,000      
Share-based payment award compensation costs 11,572 11,572
Net income (loss) 111,997 111,997
Balance at Dec. 31, 2022 $ 9 974,497 (939,363) 35,143
Balance (in Shares) at Dec. 31, 2022 9,498,000      
Shares issued for vested restricted stock units $ 1 1
Shares issued for vested restricted stock units (in Shares) 844,000      
Share-based compensation 1,271 1,271
Shares issued for sale of common stock related to private placement sale $ 1 3,149 3,150
Shares issued for sale of common stock related to private placement sale (in Shares) 1,190,000      
Net income (loss) (10,278) (10,278)
Balance at Dec. 31, 2023 $ 11 $ 978,917 $ (949,641) $ 29,287
Balance (in Shares) at Dec. 31, 2023 11,532,000